Drugs.com - Pharma Industry News

No Weight Loss Benefit Seen for Neoadjuvant Semaglutide Before Weight Loss Surgery

WEDNESDAY, March 12, 2025 -- Neoadjuvant semaglutide before metabolic and bariatric surgery (MBS) is not beneficial in terms of weight loss, according to a research letter published online March 5 in JAMA Surgery.Vasundhara Mathur, M.D., from...

Mar 12, 2025 - 18:25
 0
No Weight Loss Benefit Seen for Neoadjuvant Semaglutide Before Weight Loss Surgery
WEDNESDAY, March 12, 2025 -- Neoadjuvant semaglutide before metabolic and bariatric surgery (MBS) is not beneficial in terms of weight loss, according to a research letter published online March 5 in JAMA Surgery.Vasundhara Mathur, M.D., from...
Read More

Tags:

Previous Article

Minimal TV Viewing May Cut ASCVD Risk in Those With T2DM Genetic Risk

Next Article

ASTRO Issues Clinical Guideline for Use of Radiation Therapy in Anal Cancer

Related Posts

Sotagliflozin Cuts MACE Rate in Patients With T2DM, CKD, CVD Risk Factors

Sotagliflozin Cuts MACE Rate in Patients With T2DM, CKD...

Mar 3, 2025  0

2.3 Million New Female Breast Cancer Cases Seen Globally in 2022

2.3 Million New Female Breast Cancer Cases Seen Globall...

Feb 25, 2025  0

ADHD Symptoms Linked to Onset of Nicotine, Tobacco Use in Youth

ADHD Symptoms Linked to Onset of Nicotine, Tobacco Use ...

Feb 14, 2025  0